IP Library Granted Patent US 10,898,256
Granted Patent B2
US 10,898,256 · App. 15/177,456 · Granted Jan 26, 2021

Surgical system with user adaptable techniques based on tissue impedance

Inventors: David C. Yates (West Chester, OH); Kristen G. Denzinger (Cincinnati, OH); Kevin L. Houser (Springboro, OH)
Assignee: Ethicon LLC
A61B18/1206A61B18/1233A61B18/1445A61B18/1482A61B5/053A61B5/4836A61B2017/00017A61B2017/00026A61B2017/00039A61B2017/00084A61B2017/320093A61B2017/320094A61B2017/320095A61B2018/0088A61B2018/00589A61B2018/00601A61B2018/00607A61B2018/00642A61B2018/00648A61B2018/00654A61B2018/00678A61B2018/00702A61B2018/00791A61B2018/00875A61B2018/00994A61B2018/1452A61B2562/0261
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,898,256
App. No.
15/177,456
Filed
Jun 9, 2016
Granted
Jan 26, 2021
Kind
B2
Art Unit
3794
USPC
606/27
Abstract

A method for treating tissue includes applying an energy modality to tissue at an amplitude, measuring tissue impedance of the tissue, modulating application of the energy modality based on the measured tissue impedance, and ceasing application of the energy modality when a termination parameter is met.

Claims (40)

1. A surgical instrument for coagulating and dissecting tissue, the surgical instrument comprising:

a processor;

an end effector at a distal end of the surgical instrument, the end effector configured to interact with tissue, the end effector comprising:

a clamp arm comprising an electrode;

an ultrasonic blade;

an ultrasonic transducer acoustically coupled to the ultrasonic blade and configured to receive a drive signal from a generator to cause ultrasonic motion of the ultrasonic blade and deliver ultrasonic energy to the ultrasonic blade;

wherein the processor is configured to:

cause the end effector to deliver either testing RF energy or testing ultrasonic energy to tissue engaged with the surgical instrument, the testing RF energy and the testing ultrasonic energy comprising a low enough level of energy to not deform the tissue;

measure tissue impedance of the tissue engaged with the surgical instrument;

cease delivery of the testing RF energy or delivery of the testing ultrasonic energy when the measured tissue impedance matches a predetermined threshold value;

estimate at least one tissue parameter based at least partially on the measured tissue impedance, the at least one tissue parameter comprising a physical characteristic about the tissue;

generate a tissue model based on the at least one estimated tissue parameter, the tissue model modelling, at least in part, a desired bathtub impedance curve for the measured tissue impedance, and comprising data points each having a target tissue impedance value and a time value, the desired bathtub impedance curve comprising a curve wherein:

energy is delivered to the tissue at a first time to generate an initial level of impedance;

energy continues to be delivered at a second time after the first time to generate a second level of impedance that is lower than the initial level of impedance; and

energy continues to be delivered at a third time after the second time to generate a third level of impedance that is higher than the initial level of impedance;

generate a control technique configured to control delivery of surgical RF energy or surgical ultrasonic energy using the generated tissue model, the surgical RF energy and the surgical ultrasonic energy comprising a high enough level of energy to coagulate or dissect the tissue; and

control application of the surgical RF energy or the surgical ultrasonic energy using the control technique such that application of the surgical RF energy or the surgical ultrasonic energy generates an impedance profile over time that adheres to the tissue model as a function of time.

2. The surgical instrument of claim 1 , wherein the predetermined threshold value corresponds to a boiling point of fluid in the tissue.

3. The surgical instrument of claim 1 , wherein generating the tissue model comprises generating a target impedance trajectory as a function of the measured tissue impedance and a predetermined desired rate of change of tissue impedance.

4. The surgical instrument of claim 3 , wherein the target impedance trajectory includes a plurality of target tissue impedance values for each of a plurality of points of time.

5. The surgical instrument of claim 3 , wherein the processor is configured to drive tissue impedance along the target impedance trajectory by adjusting the surgical ultrasonic energy delivered to the ultrasonic blade so that the tissue impedance matches a predetermined tissue impedance value for a predetermined time period.

6. A generator for delivering energy to a surgical instrument for coagulating and dissecting tissue, the surgical instrument comprising an end effector at a distal end thereof, the end effector configured to interact with tissue, the end effector comprising a clamp arm, an electrode, an ultrasonic blade, an ultrasonic transducer acoustically coupled to the ultrasonic blade and configured to receive a drive signal from the generator to cause ultrasonic motion of the ultrasonic blade and deliver ultrasonic energy to the ultrasonic blade, the generator comprising:

a first drive circuit configured to deliver a drive signal to the ultrasonic transducer;

a second drive circuit configured to deliver radio frequency (RF) energy to the electrode; and

a processor configured to control the first drive circuit and the second drive circuit, and wherein the processor is configured to:

control the second drive circuit to deliver testing RF energy to the electrode that is engaged with tissue, or the first drive circuit to deliver testing ultrasonic energy to the ultrasonic blade that is engaged with the tissue, the testing RF energy and the testing ultrasonic energy comprising a low enough level of energy to not deform the tissue;

measure a tissue impedance of the tissue engaged with the surgical instrument;

control the second drive circuit to cease delivery of the testing RF energy or the first drive circuit to cease delivery of the testing ultrasonic energy when the measured tissue impedance matches a predetermined threshold value;

estimate at least one tissue parameter based at least partially on the measured tissue impedance, the at least one tissue parameter comprising a physical characteristic about the tissue;

generate a tissue model based on the at least one estimated tissue parameter, the tissue model modelling, at least in part, a desired bathtub impedance curve for the measured tissue impedance, and comprising data points each having a target tissue impedance value and a time value, the desired bathtub impedance curve comprising a curve wherein:

energy is delivered to the tissue at a first time to generate an initial level of impedance;

energy continues to be delivered at a second time after the first time to generate a second level of impedance that is lower than the initial level of impedance; and

energy continues to be delivered at a third time after the second time to generate a third level of impedance that is higher than the initial level of impedance;

generate a control technique configured to control delivery of surgical RF energy or surgical ultrasonic energy using the generated tissue model, the surgical RF energy and the surgical ultrasonic energy comprising a high enough level of energy to coagulate or dissect the tissue; and

control application of the surgical RF energy or the surgical ultrasonic energy using the control technique such that application of the surgical RF energy or the surgical ultrasonic energy generates an impedance profile over time that adheres to the tissue model as a function of time.

7. The generator of claim 6 , wherein generating the tissue model comprises generating a target impedance trajectory as a function of the measured tissue impedance and a predetermined desired rate of change of tissue impedance.

8. The surgical instrument of claim 1 , wherein the tissue model further comprises a post-bathtub desired level of impedance that is held constant over time, and controlling the application of the surgical RF energy or the surgical ultrasonic energy using the control technique further comprises controlling the impedance, after the desired bathtub impedance curve has been achieved, to match the post-bathtub desired level of impedance.

9. The surgical instrument of claim 1 , wherein the tissue model further comprises a post-bathtub desired level of impedance whose rate of change is held constant over time, and controlling the application of the surgical RF energy or the surgical ultrasonic energy using the control technique further comprises controlling the impedance, after the desired bathtub impedance curve has been achieved, to match the post-bathtub desired level of impedance.

10. The generator of claim 6 , wherein the tissue model further comprises a post-bathtub desired level of impedance that is held constant over time, and controlling the application of the surgical RF energy or the surgical ultrasonic energy using the control technique further comprises controlling the impedance, after the desired bathtub impedance curve has been achieved, to match the post-bathtub desired level of impedance.

11. The generator of claim 6 , wherein the tissue model further comprises a post-bathtub desired level of impedance whose rate of change is held constant over time, and controlling the application of the surgical RF energy or the surgical ultrasonic energy using the control technique further comprises controlling the impedance, after the desired bathtub impedance curve has been achieved, to match the post-bathtub desired level of impedance.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 6, 2021
From: ETHICON LLC
To: CILAG GMBH INTERNATIONAL
Reel/Frame 056983/0569 →
CHANGE OF NAME Recorded Dec 14, 2017
From: ETHICON ENDO-SURGERY, LLC
To: ETHICON LLC
Reel/Frame 045603/0586 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 7, 2016
From: YATES, DAVID C.; DENZINGER, KRISTEN G.; HOUSER, KEVIN L.
To: ETHICON ENDO-SURGERY, LLC
Reel/Frame 040234/0859 →
Continuity (7)
Provisional Application 62186984 · Jun 30, 2015
Provisional Application 62235260 · Sep 30, 2015
Provisional Application 62235368 · Sep 30, 2015
Provisional Application 62235466 · Sep 30, 2015
Provisional Application 62279635 · Jan 15, 2016
Provisional Application 62330669 · May 2, 2016
Related Publication 20170000542A1 · Jan 5, 2017
Cited By (71)
US 12,193,636 US 12,193,698 US 12,193,766 US 12,201,339 US 12,207,817 US 12,226,151 US 12,226,166 US 12,228,987 US 12,232,729 US 12,235,697 US 12,239,320 US 12,239,353 US 12,239,360 US 12,256,995 US 12,262,937 US 12,268,408 US 12,293,432 US 12,295,639 US 12,295,674 US 12,303,159 US 12,310,586 US 12,315,036 US 12,318,152 US 12,329,437 US 12,329,467 US 12,336,747 US 12,343,063 US 12,349,961 US 12,354,186 US 12,369,960 US 12,369,994 US 12,376,855 US 12,376,896 US 12,383,115 US 12,396,806 US 12,402,906 US 12,408,967 US 12,426,912 US 12,433,508 US 12,444,094 US 12,453,571 US 12,458,351 US 12,462,439 US 12,465,384 US 12,488,512 US 12,493,996 US 12,500,948 US 12,505,584 US 12,514,584 US 12,521,191 US 12,549,622 US 12,574,434 US 12,575,855 US 12,582,457 US 12,629,194 US 12,629,200 US 12,636,066 US 12,639,250 US 12,648,789 US 12,653,602 US 12,661,175 US 12,661,188 US 12,670,670 US 12,672,922 US 12,682,578 US 12,682,579 US 12,697,178 US 12,702,409 US 12,702,466 US 12,708,427 US 12,712,326